Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gomatou (Athens, Greece), C. Masaoutis (Athens, Greece), I. Vamvakaris (Athens, Greece), E. Bouros (Athens, Greece), D. Bouros (Athens, Greece). TERT expression in lung cancer associated with IPF: a case-control study. 3273

Member's Comments

No comment yet.

Related content which might interest you: Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 MUC2MUC5B and TOLLIP variants: no association with disease progression and survival in an IPF cohort Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 CTLA-4, CD28, and ICOS gene polymorphisms in non-small cell lung cancer in a Polish population- case control study Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010 Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002 A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Airway gene expression as a link between COPD and lung cancer Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Analysis and comparison of the transcriptome of COPD patients with and without lung cancer Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 The expression of miR185, miR29a and their targets in IPF and lung cancer (LC). A BALF study. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 A prospective study to detect ICIs’ associated Myocarditis, among patients treated for lung cancer Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018